All images were acquired at 100 cm SID using the integrating dosimetry mode at the maximum available dose rate: 600 MU/min at 6 and 10 MV for both EPIDs, and 1400 MU/min at 6 MV FFF and 2400 MU/min at 10 MV FFF for the aS1200. Different fields were delivered from 3×3 cm 2 up to the maximum accommodated by the panel to verify the CAX signal increased with field size. Dose linearity was investigated by irradiating 10×10 cm 2 fields from 1 to 100 MU and considering the signal on the CAX. Ghosting was assessed by delivering three 100 MU fields: a 10×10 cm 2 , followed immediately by a 20×20 cm 2 then a second 10×10 cm 2 and measuring residual signal ±7.5 cm from the CAX. The ratio of signals ±3 cm vertically from the CAX was calculated for fields > 8×8 cm 2 to determine the impact of backscatter. The Modulation Transfer Function (MTF) was determined at each energy from images of an opaque angled edge. All image analysis was performed using IQWorks. A number of IMRT and VMAT plans were verified pretreatment using Portal Dosimetry (PD, Varian Medical Systems) and in vivo using Dosimetry Check (DC, Math Resolutions LLC). Results: Saturation was not evident and dose linearity was within ±1.0% at all energies / dose-rates for both detectors. Signal lag (Fig 1a) was <1.5% for the aS1000 and <0.6% for the aS1200. Differential backscatter (Fig 1b) from the aS1000 support arm increases with field size up to a maximum of 2.5%. On the aS1200 it is negligible (<0.5%) and independent of field size due to additional shielding material attached to the back of the panel. However, the increased backscatter overall results in marginally poorer MTF at lower spatial frequencies ( Fig  1c) . All patient plans evaluated using PD yielded gamma pass rates (gamma < 1) of 100% when using criteria of 3%/3mm and >99.5% using criteria of 2%/2mm. Test plans with 2.5 mm MLC leaf errors required 2%/2mm to be detected on the aS1200 compared with 3%/3mm on the aS1000. This may be due to the higher bit depth and lower signal lag. IVD was successfully performed for large field, multi arc VMAT plans, with gamma pass rates > 90% at 5%/3mm for irradiated areas of side up to 26 cm at 150 cm SID.
Conclusions:
The aS1200 improves on the aS1000 as a dosimeter, overcoming limitations of the previous device and permitting more accurate measurements. Performance was found to be superior to the previous generation detector in every metric, except for a small reduction in MTF at low spatial frequencies which is not clinically significant. In particular, the impact of support arm backscatter is negligible and the ability to image large field and FFF beams allows the new EPID to be applied to a wider range of pre-treatment and IVD imaging scenarios. Purpose/Objective: Polymer gel dosimeters are tissue equivalent materials fabricated from radiation sensitive chemicals which, upon irradiation, polymerize as a function of absorbed radiation dose. Gel dosimeters can uniquely record the radiation dose distribution in three-dimensions (3D). Such dose distribution can be subsequently imaged by MRI, optical computerized tomography (OCT), x-ray CT or ultrasound. We describe the fabrication and physical properties of a new gel with favorable characteristics for the 3D Gel dosimetry applications when compared to the existing gel compositions. Materials and Methods: Three novel normoxic hydroxylethyl-methacrylate (HEMAGAT) gel variations were fabricated using formulation given in Table 3 ( Fig.1 ). Its properties (absorbance and stability) were compared to three Acrylamid (PAGAT) polymer gels designed using formulation given in Table 1 (Fig.1) , as well as four N-isopropyl-acryl-amide (NIPAMGAT) gels (Table 2, Fig.1 ). Each sample vial filled with gel was placed in a water phantom, and irradiated using a 6 MV photon beam from a Varian medical linear accelerator to various doses. Samples were transferred back to refrigerator and kept for 24 hours prior to absorption measurements. Absorption spectra of irradiated gel samples were measured in a range from 350 -650 nm using UV/VIS spectrophotometer, model Lambda 850, from Perkin-Elmer, USA. Three samples at each absorbed dose were measured, but no significant differences in their characteristics were found during measurements. To test the post-irradiation stability of polymerized gels, we were sampling the gel response at two dose levels (6 and 15 Gy) once a day for seven days. Results: Figure 1 compares the dose response (absorbance sampled at 500 nm) for the three gel models studied. The first two gel models deviate from linear behavior at doses well below 20 Gy, while the novel HEMAGAT gel model retains its linear behavior even at doses of up to 30 Gy. The highest sensitivity of the new gel model was exhibited by the first chemical variation containing 4 w/w% of HEMA (2hydroxy-ethyl-methacrylate). Results demonstrated that the stability of novel HEMAGAT gel depend strongly on concentration of hydroquinone (HQ). For gel variations presented here (Fig.1, Table 3 ) results show no change (less than ±2%; 1σ) in the sample responses of up to seven days after irradiation. Conclusions: All three variations of the new gel composition described exhibit favorable linear behavior dose response in a broader dose range (double) than the two existing gel compositions used for 3D Gel dosimetry applications. Also, the novel gel composition showed no apparent change in response with post-irradiation time. Purpose/Objective: Recently, a number of studies investigating the difference in cell survival after irradiation with unflattened (FFF) compared to flattened beams (FF). Most of these studies were, on the one hand, performed under 'normal' oxygen conditions (21 %) and, on the other hand, dose homogeneity was often established using compensators or intensity modulation. The reproducibility of such setups has not yet been investigated. The aim of this study was to design a phantom capable of establishing hypoxic and normoxic conditions, providing a region of homogeneous dose distribution using static fields only and the possibility to precisely monitor the delivered dose to the cells for each experiment. Materials and Methods: A VersaHD (Elekta, Crawley, UK) linac was utilized, which was commissioned to produce 10 MV FF and FFF beams. Doses of 0.5, 1, 2, 4 and 6 Gy were delivered to HaCaT (human keratinocytes) cells from a gantry angel of 180° using a static 10x10 cm² field. The cells were grown and irradiated in chamber slides, which consist of two wells each with inner dimensions of 2x2 cm². Only one well was used for the cells, the other one was filled with culture medium to provide scatter material. A PMMA insert was manufactured to fit the chamber slide between solid water slabs in a depth of 10 cm. Two holes were drilled through the PMMA insert in order to provide gas exchange, either ambient air for normoxic or nitrogen for hypoxic conditions. Dose homogeneity and monitor units necessary to deliver the specified doses to the cells were assessed using EBT3 films. . In order to determine the reproducibility of the setup of each cell irradiation, a Farmer chamber TM 30006 (PTW, Freiburg, Germany) was positioned downstream the beam line. The described setup is depicted in Fig. 1a . Cell survival was investigated in a clonogenic assay. Based on that, α and β values of the cell survival curves were calculated for cells irradiated with FF and FFF beams. Results: The film measurements showed that when using the chamber slides it is possible to establish an isolated region with cells where a dose homogeneity within ± 2% can be achieved even in FFF mode. The Farmer chamber measurements revealed a reproducibility of the dose between the individual cell irradiations within 0.5%. Alpha values of 0.16 and 0.11 were determined of cells irradiated with FF (dose rate ~4 Gy/min) and FFF beams (dose rate ~16 Gy/min), respectively. Both values agreed within their uncertainty. Beta values were 0.05 for both FF and FFF beams.
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PD-0383 A phantom suitable for cell survival investigations using flattened and unflattened photon beams
Conclusions:
An experimental setup could be established for reproducible cell irradiations in FF and FFF mode with sufficient dose homogeneity, without altering the beam itself or by the use of compensators or intensity modulation. Furthermore, this experimental setup enables simulation of different oxygen conditions. So far, no difference in survival of HaCaT cells was detected between irradiation with FFF or FF beams.
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The XX Postal TLD Audit Programme: analysis of 10,660 results J. Izewska 1 , M. Wanklyn 2 , P. Grochowska 1 , P. Purpose/Objective: With the aim of improving the accuracy and consistency of clinical dosimetry in hospitals world-wide, the XX Thermoluminescence Dosimetry (TLD) Postal Audit Program has been operating since 1969. In this study, we explore the dependence of the quality of clinical dosimetry in participating institutions on several key infrastructure characteristics. Materials and Methods: The Postal Audit Program compares the dose read from the mailed TLD with that stated to have been delivered by the Institution. Agreement to within ±5% is regarded as being acceptable with larger deviations triggering follow-up actions. Of particular interest in this study was the dependence of clinical dosimetry quality on i) age of the treatment machine, ii) 60 Co vs linac, iii) number of machines in the participating centre, iv) elapsed time since the last dosimetry system calibration v) whether the audit was the first one or a subsequent one and vi) the dosimetry protocol used (a sub-set of 7182 TLDs). Quality, in this context, is defined as the percentage of results within the XX's criterion of acceptability of ±5%. Also, it is to be noted that the term 'clinical dosimetry' encompasses calibration of the institution's beam, the institution's dosimetry calculations and irradiation of the Postal Audit TLDs as it was clearly not possible to isolate these different contributors to the final result.
